Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections

抗真菌 重症监护医学 抗真菌药 临床试验 疾病 医学 人口 抗真菌药 抗药性 生物 生物信息学 病理 皮肤病科 微生物学 环境卫生
作者
Chin Fen Neoh,Sharon C.‐A. Chen,Fanny Lanternier,Shio Yen Tio,Catriona L Halliday,Sarah E. Kidd,David C. M. Kong,Wieland Meyer,Martin Hoenigl,Monica A. Slavin
出处
期刊:Clinical Microbiology Reviews [American Society for Microbiology]
卷期号:37 (2): e0000423-e0000423 被引量:58
标识
DOI:10.1128/cmr.00004-23
摘要

SUMMARY AlthoughScedosporiumspecies andLomentospora prolificansare uncommon causes of invasive fungal diseases (IFDs), these infections are associated with high mortality and are costly to treat with a limited armamentarium of antifungal drugs. In light of recent advances, including in the area of new antifungals, the present review provides a timely and updated overview of these IFDs, with a focus on the taxonomy, clinical epidemiology, pathogenesis and host immune response, disease manifestations, diagnosis, antifungal susceptibility, and treatment. An expansion of hosts at risk for these difficult-to-treat infections has emerged over the last two decades given the increased use of, and broader population treated with, immunomodulatory and targeted molecular agents as well as wider adoption of antifungal prophylaxis. Clinical presentations differ not only between genera but also across the differentScedosporiumspecies.L. prolificansis intrinsically resistant to most currently available antifungal agents, and the prognosis of immunocompromised patients with lomentosporiosis is poor. Development of, and improved access to, diagnostic modalities for early detection of these rare mold infections is paramount for timely targeted antifungal therapy and surgery if indicated. New antifungal agents (e.g., olorofim, fosmanogepix) with novel mechanisms of action and less cross-resistance to existing classes, availability of formulations for oral administration, and fewer drug-drug interactions are now in late-stage clinical trials, and soon, could extend options to treat scedosporiosis/lomentosporiosis. Much work remains to increase our understanding of these infections, especially in the pediatric setting. Knowledge gaps for future research are highlighted in the review.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
秀丽的冰萍完成签到,获得积分10
刚刚
冰_完成签到 ,获得积分10
1秒前
VIOLET发布了新的文献求助10
1秒前
俏皮的钻石完成签到 ,获得积分10
2秒前
2秒前
2秒前
fantasy的应助被GamAooL采纳,获得10
2秒前
海岸线发布了新的文献求助10
3秒前
3秒前
英姑的应助被山复尔尔采纳,获得10
3秒前
小二郎的应助被sttise采纳,获得10
3秒前
合适高跟鞋完成签到 ,获得积分20
4秒前
wf完成签到,获得积分10
5秒前
哇哈哈发布了新的文献求助10
5秒前
哈基咪完成签到 ,获得积分10
6秒前
6秒前
6秒前
12发布了新的文献求助30
6秒前
7秒前
yhr发布了新的文献求助10
7秒前
小蘑菇的应助被LIU采纳,获得10
8秒前
8秒前
荼蘼发布了新的文献求助30
8秒前
8秒前
9秒前
浮云发布了新的文献求助10
9秒前
呆萌白薇完成签到,获得积分10
9秒前
10秒前
10秒前
Lio发布了新的文献求助10
11秒前
z8131110完成签到,获得积分10
12秒前
跳跳豆完成签到,获得积分10
12秒前
所所的应助被可耐的如萱采纳,获得10
13秒前
13秒前
13秒前
General发布了新的文献求助10
13秒前
咸鱼大帝完成签到,获得积分10
14秒前
Ren的应助被daomaihu采纳,获得100
14秒前
情怀的应助被山复尔尔采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241